KRYS Stock Price Prediction 2026-2027
AI-powered forecast for Krystal Biotech Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$267.41
Price Targets for 2027
Bear Case
$286.65
+7.2%
Base Case
$314.00
+17.4%
Bull Case
$341.35
+27.7%
Prediction Tracking
Coming Soon for KRYS
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for KRYS
Key Factors Influencing KRYS Stock
Bullish Factors
- Revenue growth of 0.2% year-over-year
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- High P/E ratio of 37.9x may limit upside
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $314.00.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for KRYS
Frequently Asked Questions
What is KRYS stock price today?
KRYS (Krystal Biotech Inc) stock is trading at $267.41 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is KRYS stock going up or down today?
KRYS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy KRYS stock now?
The decision to buy KRYS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is KRYS a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for KRYS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is KRYS stock overvalued or undervalued?
KRYS currently trades at a P/E ratio of 37.87, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if KRYS is fairly priced.
What is KRYS's P/E ratio?
KRYS has a price-to-earnings (P/E) ratio of 37.87, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is KRYS's market cap?
KRYS (Krystal Biotech Inc) has a market capitalization of $7.62 billion, making it a small-cap stock.
What is KRYS's price to book ratio?
KRYS trades at a price-to-book (P/B) ratio of 6.25, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does KRYS pay dividends?
KRYS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is KRYS's dividend yield?
KRYS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is KRYS stock a good long-term investment?
KRYS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is KRYS's revenue growth rate?
KRYS has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is KRYS profitable?
Yes, KRYS is profitable with a profit margin of 0.5%. This indicates the company generates 0.5 cents of profit for every dollar of revenue.
What are the risks of investing in KRYS?
Key risks for KRYS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does KRYS compare to its competitors?
Compare KRYS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KRYS's performance and positioning.
What is KRYS's stock price target for 2026?
Our AI model provides price targets for KRYS based on fundamental analysis: Bull case $347.63 (+30%), Base case $307.52 (+15%), Bear case $240.67 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about KRYS?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for KRYS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is KRYS's next earnings report?
KRYS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.